Effects of sample matrix in the measurement of antithrombin by LC-MS: A role for immunocapture.
AT, antithrombin
Anticoagulants
Antithrombin
BD, Becton, Dickinson and Company
CV, coefficient of variation
FA, formic acid
Immunocapture
LC, liquid chromatography
LUVDS, Leiden University Medical Center Voluntary Donor Service
MRM, multiple reaction monitoring
PIC, protease inhibitor cocktail
QC, quality control
Quantitative clinical chemistry proteomics
SST, system suitability test
Sample matrix
VHH, single variable domain on a heavy chain
Journal
Journal of mass spectrometry and advances in the clinical lab
ISSN: 2667-145X
Titre abrégé: J Mass Spectrom Adv Clin Lab
Pays: Netherlands
ID NLM: 101776811
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
23
09
2022
revised:
05
01
2023
accepted:
06
01
2023
entrez:
24
1
2023
pubmed:
25
1
2023
medline:
25
1
2023
Statut:
epublish
Résumé
The sample matrix composition, which is greatly affected by the type of blood collection tube used during phlebotomy, is of major importance in laboratory testing as it can influence test results. We developed an LC-MRM-MS test to molecularly characterize antithrombin in citrate plasma. The test principle differs greatly from traditional laboratory tests and the influence of varying plasma sample matrices is largely unknown. To identify whether variations in sample matrix affect the LC-MRM-MS test for antithrombin and assess whether sample pre-processing by immunocapture reduces matrix-specific effects. Samples (n = 45) originating from four different blood collection tubes (sodium citrate, lithium heparin, K Deming regression analysis of directly processed samples revealed slopes deviating >5% from the line of identity for at least six out of 22 peptides in all matrices. Significant differences between all matrices were found upon analysis by ANOVA for at least 10 peptides. Pre-processing by immunocapture led to slopes within 5% of the line of identity for nearly all peptides of the matrices. Furthermore, significant differences between matrices after immunocapture were only observed for four peptides. Variations in the sample matrix affect the measurement of antithrombin by LC-MRM-MS, but observed effects are greatly reduced upon pre-processing by immunocapture.
Identifiants
pubmed: 36691568
doi: 10.1016/j.jmsacl.2023.01.002
pii: S2667-145X(23)00002-0
pmc: PMC9860377
doi:
Types de publication
Journal Article
Langues
eng
Pagination
61-65Informations de copyright
© 2023 THE AUTHORS.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Adv Clin Chem. 1998;33:133-68
pubmed: 10086176
Clin Chem Lab Med. 2017 Oct 26;55(12):1849-1856
pubmed: 29031018
Crit Rev Clin Lab Sci. 2018 Nov;55(7):480-500
pubmed: 30309270
Thromb Res. 2015 Jun;135(6):1179-85
pubmed: 25837307
Clin Chem Lab Med. 2022 Sep 08;61(1):55-66
pubmed: 36069790
J Gen Physiol. 1948 Nov;32(2):191-202
pubmed: 18891145
Clin Chem Lab Med. 2006;44(6):750-9
pubmed: 16729864
J Thromb Haemost. 2013 Oct;11(10):1844-9
pubmed: 23910795
J Proteome Res. 2010 Oct 1;9(10):5422-37
pubmed: 20722421
Clin Chem Lab Med. 2018 Jun 27;56(7):1035-1045
pubmed: 29455188
Clin Chem Lab Med. 2018 Sep 25;56(10):1704-1714
pubmed: 29708875
J Thromb Haemost. 2021 Nov;19(11):2857-2861
pubmed: 34455689
Clin Chem Lab Med. 2015 May;53(6):833-5
pubmed: 25719329
Am J Clin Pathol. 2005 Dec;124(6):902-9
pubmed: 16416740